HNRNPA0 (heterogeneous nuclear ribonucleoprotein A0) is an mRNA-binding protein that plays crucial roles in post-transcriptional gene regulation and cellular processes. The protein functions primarily through binding to AU-rich elements (AREs) in mRNA 3'-UTRs, where it regulates mRNA stability and translation 1. HNRNPA0 demonstrates diverse mechanistic functions including mRNA stabilization, nuclear-cytoplasmic trafficking regulation, and protein-lncRNA interactions. It stabilizes p27 mRNA in the cytoplasm, contributing to cell cycle control 1, and regulates HIV-1 replication through multiple mechanisms including LTR activity modulation, mRNA export, and programmed ribosomal frameshifting 2. The protein also interacts with long non-coding RNAs, such as MY34UE-AS in leukemia cells to promote MYB expression 3. Disease relevance is significant, as HNRNPA0 variants are associated with hereditary colorectal cancer predisposition 45 and cognitive decline in aging 6. The protein shows altered expression in various cancers and HIV-1 infection 27. Clinically, HNRNPA0 represents a potential therapeutic target, with its expression levels serving as biomarkers for cancer prognosis and treatment response in p53-defective tumors and viral infections.